Childhood lichen sclerosus: A long-term follow-up

Pediatric Dermatology

Volumn 27, Issue 1, 2010, Pages 101-103

  Patrizi, Annalisa ^a   Gurioli, C ^a   Medri, M ^a   Neri, I ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DRUG EFFECT; DRUG SAFETY; FEMALE; FOLLOW UP; GENITAL PAIN; HUMAN; INFLAMMATION; LICHEN SCLEROSUS ET ATROPHICUS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCAR FORMATION; SCHOOL CHILD; URINARY DYSFUNCTION; VULVITIS;

ADMINISTRATION, TOPICAL; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; ATROPHY; CHILD; CHILD, PRESCHOOL; CLOBETASOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VULVAR LICHEN SCLEROSUS;

EID: 77649165360     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.01050.x     Document Type: Article

References (4)

1. Fischer G, Rogers M. Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol 1997 14 : 235 238.
2. Smith YR, Quint EH. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus. Obstet Gynecol 2001 98 : 588 591.
3. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001 44 : 803 806.
4. Cooper SM, Gao XH, Powell J et al. Does the treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004 140 : 702 706.